130 related articles for article (PubMed ID: 2968567)
21. Merthiolate hypersensitivity and vaccination.
Förström L; Hannuksela M; Kousa M; Lehmuskallio E
Contact Dermatitis; 1980 Jun; 6(4):241-5. PubMed ID: 6447032
[TBL] [Abstract][Full Text] [Related]
22. Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine?
Kirkland LR
South Med J; 1990 May; 83(5):497-9. PubMed ID: 2140468
[TBL] [Abstract][Full Text] [Related]
23. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
24. Allergic reactions to Merthiolate (Thimerosal).
Fisher AA
Cutis; 1981 Jun; 27(6):580, 582, 587. PubMed ID: 6453701
[No Abstract] [Full Text] [Related]
25. Why thimerosal allergy?
Möller H
Int J Dermatol; 1980; 19(1):29. PubMed ID: 7358436
[No Abstract] [Full Text] [Related]
26. Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020 Apr; 30(2):86-100. PubMed ID: 32327401
[TBL] [Abstract][Full Text] [Related]
27. Elicitation of contact lens allergy to thimerosal by eye cream.
Whittington CV
Contact Dermatitis; 1985 Sep; 13(3):186. PubMed ID: 2932285
[No Abstract] [Full Text] [Related]
28. [A case of allergic drug contact dermatitis].
Miranda A; Quiñones PA
Actas Dermosifiliogr; 1980; 71(7-8):301-2. PubMed ID: 6451153
[No Abstract] [Full Text] [Related]
29. Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations.
Calogiuri G; Garvey LH; Romita P; Macchia L; Foti C
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):91-100. PubMed ID: 27834127
[TBL] [Abstract][Full Text] [Related]
30. Reactions induced by the concurrent use of thimerosal and tetracycline.
Crook TG; Freeman JJ
Am J Optom Physiol Opt; 1983 Sep; 60(9):759-61. PubMed ID: 6681469
[TBL] [Abstract][Full Text] [Related]
31. Letter: Thimerosal reaction and cell-mediated immunity.
Hansson H; Möller H
N Engl J Med; 1974 May; 290(21):1202. PubMed ID: 4824019
[No Abstract] [Full Text] [Related]
32. [The problems of contact reaction to mertiolate (author's transl)].
Novák M; Kvícalová E
Cesk Dermatol; 1978; 53(5):313-7. PubMed ID: 729014
[No Abstract] [Full Text] [Related]
33. Reactions to thimerosal in hepatitis B vaccines.
Rietschel RL; Adams RM
Dermatol Clin; 1990 Jan; 8(1):161-4. PubMed ID: 2137393
[TBL] [Abstract][Full Text] [Related]
34. [Mercury-induced hypersensitivity rare after subcutaneous injection of vaccines].
Taranger J
Lakartidningen; 1990 Apr; 87(16):1345. PubMed ID: 2329881
[No Abstract] [Full Text] [Related]
35. Ocular inflammation in patients using soft contact lenses.
Rietschel RL; Wilson LA
Arch Dermatol; 1982 Mar; 118(3):147-9. PubMed ID: 6175282
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial safety of eye drops and their adjustment].
Háze K; Dolezalová V
Cesk Farm; 1981 Nov; 30(9):319-21. PubMed ID: 7317956
[No Abstract] [Full Text] [Related]
37. Caution on use of merthiolate in the ear.
Cotton RT
J Otolaryngol; 1988 Aug; 17(5):260. PubMed ID: 3216451
[No Abstract] [Full Text] [Related]
38. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products.
Magos L
J Appl Toxicol; 2001; 21(1):1-5. PubMed ID: 11180274
[No Abstract] [Full Text] [Related]
39. Allergic contact dermatitis from thimerosol in a soft contact lens wearer.
Sertoli A; Di Fonzo E; Spallanzani P; Panconesi E
Contact Dermatitis; 1980 Jun; 6(4):292-3. PubMed ID: 7398292
[No Abstract] [Full Text] [Related]
40. [Multicenter survey related to the frequency of positive patch tests with mercury and thiomersal].
Lachapelle JM; Chabeau G; Ducombs G; Lacroix M; Martin P; Reuter G; Marot L
Ann Dermatol Venereol; 1988; 115(8):793-6. PubMed ID: 2974266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
